Andy Pasternak Horizon Therapeutics Public LTD CO (HZNP) insider trading activity

Andy Pasternak is EVP, Chief Strategy Officer of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 0 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Oct 06, 2023, when has been sold 56,338 shares (Ordinary Shares) at a price of $116.5 per share, resulting in proceeds of $6,563,377. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Andy Pasternak Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 06 2023	SELL Sale (or disposition) back to the issuer	$6,563,377 $116.5 p/Share	56,338 Reduced 100.0%	0 Ordinary Shares
Jan 17 2023	SELL Open market or private sale	$3,066,390 $113.03 p/Share	27,129 Reduced 32.5%	56,338 Ordinary Shares
Dec 30 2022	SELL Payment of exercise price or tax liability	$4,473,819 $113.8 p/Share	39,313 Reduced 32.02%	83,467 Ordinary Shares
Dec 30 2022	BUY Exercise of conversion of derivative security	-	88,733 Added 41.95%	122,780 Ordinary Shares
Dec 13 2022	SELL Open market or private sale	$3,397,331 $112.61 p/Share	30,169 Reduced 46.98%	34,047 Ordinary Shares
Dec 13 2022	BUY Exercise of conversion of derivative security	$686,369 $29.52 p/Share	23,251 Added 26.58%	64,216 Ordinary Shares
Nov 01 2022	SELL Payment of exercise price or tax liability	$347,679 $63.18 p/Share	5,503 Reduced 11.84%	40,965 Ordinary Shares

Nov 01 2022	BUY Exercise of conversion of derivative security	-	12,421 Added 21.09%	46,468 Ordinary Shares
Jul 29 2022	SELL Open market or private sale	$402,307 $82.95 p/Share	4,850 Reduced 12.47%	34,047 Ordinary Shares
Jun 10 2022	SELL Open market or private sale	$65,044 $85.36 p/Share	762 Reduced 1.92%	38,897 Ordinary Shares
Feb 18 2022	SELL Open market or private sale	$124,499 $94.82 p/Share	1,313 Reduced 3.2%	39,659 Ordinary Shares
Jan 06 2022	SELL Open market or private sale	$790,154 $98.93 p/Share	7,987 Reduced 16.31%	40,972 Ordinary Shares
Jan 05 2022	SELL Payment of exercise price or tax liability	$2,210,946 $101.84 p/Share	21,710 Reduced 30.72%	48,959 Ordinary Shares
Jan 05 2022	BUY Exercise of conversion of derivative security	-	48,839 Added 40.87%	70,669 Ordinary Shares
Dec 07 2021	SELL Open market or private sale	$152,500 $100.0 p/Share	1,525 Reduced 6.53%	21,830 Ordinary Shares
Nov 04 2021	SELL Open market or private sale	$3,409,587 $113.02 p/Share	30,168 Reduced 56.36%	23,355 Ordinary Shares
Nov 04 2021	BUY Exercise of conversion of derivative security	$686,370 $29.52 p/Share	23,251 Added 30.28%	53,523 Ordinary Shares
Nov 01 2021	SELL Payment of exercise price or tax liability	$650,950 $118.29 p/Share	5,503 Reduced 15.38%	30,272 Ordinary Shares
Nov 01 2021	BUY Exercise of conversion of derivative security	-	12,421 Added 25.77%	35,775 Ordinary Shares
Sep 09 2021	SELL Open market or private sale	$2,512,163 $108.05 p/Share	23,250 Reduced 49.89%	23,354 Ordinary Shares
Sep 09 2021	BUY Exercise of conversion of derivative security	$686,340 $29.52 p/Share	23,250 Added 33.28%	46,604 Ordinary Shares
Jul 28 2021	SELL Payment of exercise price or tax liability	$395,445 $102.5 p/Share	3,858 Reduced 14.18%	23,354 Ordinary Shares
Jul 28 2021	BUY Grant, award, or other acquisition	-	8,708 Added 24.24%	27,212 Ordinary Shares
Feb 17 2021	SELL Payment of exercise price or tax liability	$91,093 $87.17 p/Share	1,045 Reduced 5.56%	17,742 Ordinary Shares
Feb 17 2021	BUY Grant, award, or other acquisition	-	2,358 Added 11.15%	18,787 Ordinary Shares

Andy Pasternak

EVP, Chief Strategy Officer

Dublin, L2

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HZNP shares.

Notify only if

Value

Insider Trading

Get notified when an Horizon Therapeutics Public LTD CO insider buys or sells HZNP shares.

Notify only if

Operation

Value

Type

News

Receive news related to Horizon Therapeutics Public Ltd Co

Track Activities on HZNP

Account